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Abstract
Purpose To discuss the requirements for long-term implantation of electronic devices with a focus on
packaging and encapsulation.
Approach Due to their intended long-term use in the human body, implants for electrical stimulation
present specific challenges to the engineers. The respective roles of packaging and encapsulation must be
clearly understood to make the most of new materials and modern machining technologies. This paper
offers an introduction to the current situation and highlights challenges for future developments.
Findings The innovative application of modern technologies may be usefull to tackle key issues of encap-
sulation and sealing of small electrical devices for long term implantation.
Originality Two examples of innovative application of alternative package manufacture and sealing
method are described.
Keywords Hermetic packaging, encapsulation, functional electrical stimulation, implanted devices.
Paper type Research paper.
I Introduction
Implantable electronic devices present specific
challenges to the designers due to their long-term
intended use within the human body. The de-
velopment of the first such devices in the late
1950s resulted from a combination of two funda-
mental technological advances. On the one hand,
the reliability of electronic devices working in hos-
tile environment had greatly improved during the
first half of the century with major progresses in
packaging. On the other hand, pioneers in neu-
rophysiology and medical engineering had raised
the general understanding of the human neuro-
motor system and how to interact with it. This
led to considerable innovations in the use of elec-
tronic devices for medical applications, with the
early percutaneous heart pacemakers appearing
in 1952 and the first implantable version in 1958.
Fifty years on the technologies have evolved and
seen the successful commercialisation of a variety
of electrical stimulation implants. Yet the pro-
duction processes are complex, the materials used
are expensive and the need for CE/FDA approval
imposes rules on the design, some of which seem
to stem less from reasonable investigation than
from an unfortunate lack of understanding of the
long-term effects of human implantation. This
paper discusses some of the technologies available
to small research groups for the production of hu-
man implants, with a focus on the challenges for
packaging and encapsulation.
A Implant parts
Most electrical stimulation implants are seen as
the combination of their two fundamental compo-
nents: an electronic circuit to produce the stimuli,
and electrodes to deliver the charges to the ner-
vous structures. These two parts are connected to
one another with a flexible cable. The circuit may
be enclosed in a hard shell, the package, while the
assembly (with or without packaging) may also be
coated in a soft shell or encapsulation.
B Implants requirements
Integrity is essential, consistency of the electronic
function must be guaranteed over the expected
life-time and under all unexpected conditions. No
leakage current must flow through the electrodes.
Corrosion is the main concern due to the humid
atmosphere and emphasis is often placed on the
hermeticity of the package and its seal which may
be tested and monitored. The encapsulant also
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Figure 1: The 5 parts of an implant: the encapsu-
lation, the circuit mainly hidden under the pack-
age, the cable and the electrode.
plays a role in preventing corrosion of all metallic
areas that cannot practically be encased. While
the package and encapsulant protect the circuitry
from the adverse environment, biocompatibility
ensures that the host is not endangered by the
device. All materials in contact with the body,
i.e. the metal of the electrodes, the packaging and
the encapsulant, must be tested for adverse tissue
reactions. Mechanically, parts of the device may
be subjected to considerable strain. They must
be robust to withstand the flexion and wear, yet
soft and smooth to prevent damaging the body.
II Materials and methods.
A Packaging
Various biocompatible materials have been used
over the years, mainly glass, ceramic (Al2O3) and
Titanium. The later is acceptable as it is pro-
tected from corrosion by a strongly passivating
oxide layer and is widely used in passive implants
such as dental implants, joint prostheses and bone
fixation screws as well as electrical stimulator en-
closures. The main issues are machinability of
the materials to create the case, the formation
of feedthroughs, the need to accommodate for a
radio antenna and the sealing process. The en-
closure must not alter the communication with
the implant controller (carried outside the body),
often established through a radio-frequency link,
and the presence of a shorted metal loop may con-
siderably decrease the performances. The need to
machine intricate shapes and the trend towards
miniaturisation further increases the difficulties
in finding suitable materials and providing ade-
quate feedthroughs and sealing methods. Proto-
typing and rapidity of alterations are essential for
small research facilities so new packaging are un-
der study that can be produced and sealed on-site
to limit the reliance on subcontractors and cut
costs. These developments must be undertaken
in parallel with the circuit design as sealing and
feedthroughs will influence the method chosen to
produce the circuit. Advances in the development
of rechargeable batteries makes it a reasonable
aim to include a power source inside the implant
rather than rely on an external battery pack pow-
ering the implant by induction (MHz). This adds
further constraints on the implant design as some
batteries, and other new components, will be de-
stroyed at temperatures well below that used in
common joining processes used to seal the pack-
age, such as soldering, brazing and anodic bond-
ing.
B Encapsulation
Often neglected or poorly understood, the en-
capsulant is essential for long term implantation.
It provides a soft and smooth coating for pack-
ages presenting sharp edges and dangerous cor-
ners that could cause cuts and bleeding within
the body. Silicone rubber, the most common
encapsulant, has a long history of implantation
and its toxicity records are well-known. Further
to its padding properties, its main function on
the implant is to prevent corrosion of all coated
metal parts by avoiding direct contact with body
fluid. Yet it is no barrier to water. Indeed,
once implanted, the encapsulation layer becomes
quickly saturated with water (a couple of days for
a 5mm thick coat). If water was to condense in
a void or gap between the encapsulant and the
substrate, the presence of a salt (residue after
cleaning stage or corrosion product) could have
dramatic consequences. It would dissolve into a
highly-concentrated solution and depending on its
solubility, osmotic pressure may drive more water
inwards, leading to further loss of adhesion and
failure [Donaldson, 1989, 1991].
The encapsulant is complementary to the pack-
age. It protects the seal, the feedthroughs and
the metal connection pads (for electrodes and an-
tenna) from corrosion. It is therefore critical to
study the adhesion properties between any encap-
sulant candidate and the other materials of the
implant and to design the implant and its package
with care to prevent the formation of voids during
the moulding and curing process. Although it is
not a barrier to water, silicone rubber may stop
ions from propagating from the package into the
body fluid. This offers the option to use a wider
variety of metals and further study is necessary to
determinate the biocompatibility of other combi-
nations of package materials and encapsulant.
C Challenges
The production of all five parts of an implant may
benefit from modern technologies. Schuettler and
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Suaning have successfully established a novel elec-
trode fabrication method using a high precision
engraving laser [Schuettler et al., 2005]. The Im-
planted Devices Group has long been a pioneer
in hermetic packaging and encapsulation [Donald-
son, 1988, 1987]. The actual challenges in these
domains are: simplify assembly with low temper-
ature sealing and new machining methods, im-
prove prototyping capabilities and response time
through faster processes and reduced reliance on
external subcontractors, prevent obsolescence and
reduce cost by investing research effort in new ma-
terials.
III Examples
In this section two alternative packaging methods
developed at the Implanted Devices Group are
presented.
A Laser soldering of lid to control
inner temperature
(a) Laser soldering of alumina lid to HTCC package.
(b) Temperature inside the package during laser solder-
ing
Figure 2: Laser soldering.
One challenge when using the current packag-
ing methods is that they all require relatively high
temperatures which could result in permanent
damages of the components being encased. Dur-
ing the development of a remote controlled stim-
ulator implant we were asked to produce a proto-
type including a rechargeable battery whose max-
imum temperature was specified as 80◦C. The so-
lution proposed uses a laser beam to locally heat
the solder and propagate the melted front around
the seal fast enough to prevent excessive heating
at the center of the package. During a sealing run,
the temperature was monitored in two places in-
side the package, corresponding to the centre and
one corner of the battery area closer to the lid
being soldered. The results are presented in fig-
ure 2(b) with a picture of the laser soldering in
progress 2(a). Despite the slow rotating speed
required to ensure a smooth continued fillet, the
temperature did not reach the critical 80◦C.
B Electroformed very small lids.
For this project the challenge was to produce a
package that could be implanted directly next
to the electrode-cuff. To limit the damages and
risks of pulling on the nerve after the electrode
placement, it was suggested to mount the pack-
age on the cuff if it could be made small enough.
As a prototype the following solution was im-
plemented, see figure 3. The package is made
of a thin (254µm) alumina substrate with mul-
tiple layers thick film tracks and dielectric, and a
copper lid, electroformed on a mandrel machined
out of steel then hardened. This method allowed
the production of small lids with very thin walls
(300µm) and a particular shape (there is an over-
hang on two sides of the lid to be soldered on the
other side of the substrate). The lids are then sol-
dered using a standard reflow oven. Hermeticity
was tested using a helium leak detector to mea-
sure the rate of helium escaping the package after
bombing it with helium under pressure for 48h.
Although this procedure is not ideal it gives a first
indication of the quality of the seal. Further tests
will follow as the results of this preliminary eval-
uation were successful. Copper is not a standard
material for human implant but this solution of-
fers the possibility to quickly produce very small
lids with dedicated shapes than can easily be al-
tered. The bio-toxicity of the metal is not an issue
for the short-term tests intended in this project as
corrosion will be prevented by the encapsulant.
IV Discussion
Titanium cases or glass enclosures anodically
bonded to silicon wafers are suitable packaging
methods for implantable electronic devices. Yet
the production processes are complex and the dif-
ficulty to create feedthroughs for the electrodes
renders these option rather unreasonable for small
research groups. Alternative methods such as
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(a) Electroformed copper lid. (b) Thick-film printed substrate.
(c) Copper lid mounted on thick film substrate with thin-film Pt electrode.
Figure 3: Fine electroformed copper lids.
Al2O3 lids glued and soldered onto alumina sub-
strates have been in use for more than 20 years
now. The circuit and feedthroughs density may
be increased when moving from screen-printed
gold and platinum tracks on Al2O3 substrates to
HTCC but this improvement comes as a compro-
mise with increased the cost and lowered versatil-
ity. Work is ongoing in developing packages that
may be produced on site, requiring a limited set of
machines and allowing rapid prototyping an easy
design alterations. A proper understanding and
recognition of the role of the encapsulant is nec-
essary to keep realistic implant design proposals
from being abandoned due to misguided interpre-
tation of official approval rules.
V Conclusion
How can we make the most of today’s technolo-
gies? Current research into alternative materials
for encapsulation, packaging, electrodes and cir-
cuit tracks together with original applications of
micro-machining methods will simplify the pro-
duction process with high yield and reliability,
leading to smaller implants, increased function-
alities and lower costs.
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